Ocular Therapeutix Newsroom

Form 144 | Ocular Therapeutix(OCUL.US) Officer Proposes to Sell 125.15K in Common Stocks

SEC FILLINGS DISCLOSED/ May 23, $Ocular Therapeutix(OCUL.US)$ Officer PRAVIN DUGEL intends to sell 21,626 shares of its common stock on May 23, with a total market value of approximately $125.15K.

moomoo News16:29 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)

TipRanksMay 10 01:41 ET

Ocular Therapeutix Price Target Cut to $14.00/Share From $16.00 by HC Wainwright & Co.

Ocular Therapeutix Price Target Cut to $14.00/Share From $16.00 by HC Wainwright & Co.

Dow JonesMay 8 15:29 ET

Ocular Therapeutix Is Maintained at Buy by HC Wainwright & Co.

Ocular Therapeutix Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 8 15:29 ET

Express News | HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Lowers Price Target to $14

BenzingaMay 8 15:19 ET

Ocular Therapeutix Price Target Cut to $22.00/Share From $24.00 by JMP Securities

Ocular Therapeutix Price Target Cut to $22.00/Share From $24.00 by JMP Securities

Dow JonesMay 8 14:18 ET

Ocular Therapeutix Is Maintained at Market Outperform by JMP Securities

Ocular Therapeutix Is Maintained at Market Outperform by JMP Securities

Dow JonesMay 8 14:18 ET

Express News | JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $22

BenzingaMay 8 14:08 ET

Ocular Therapeutix Is Maintained at Hold by TD Cowen

Ocular Therapeutix Is Maintained at Hold by TD Cowen

Dow JonesMay 8 13:08 ET

Ocular Therapeutix Price Target Cut to $7.00/Share From $11.00 by TD Cowen

Ocular Therapeutix Price Target Cut to $7.00/Share From $11.00 by TD Cowen

Dow JonesMay 8 13:08 ET

Express News | TD Cowen Maintains Hold on Ocular Therapeutix, Lowers Price Target to $7

BenzingaMay 8 12:58 ET

Ocular Therapeutix Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 23.24% TD Cowen $11 → $7 Maintains Hold 04/19/2024 181.69% HC Wainwright & Co. → $16 Reiterates

BenzingaMay 8 12:57 ET

Maintaining Buy Rating on Ocular Therapeutix: Financial Growth and Advancements in Clinical Trials Signal Strong Prospects

TipRanksMay 8 06:30 ET

Express News | Ocular Therapeutix, Inc. : H.c. Wainwright Cuts Target Price to $14 From $16

ReutersMay 8 06:12 ET

Express News | Ocular Therapeutix Inc : TD Cowen Cuts Target Price to $7 From $11

ReutersMay 8 01:32 ET

Express News | Ocular Therapeutix Q1 2024 Adj EPS $(0.28) Misses $(0.19) Estimate, Sales $14.774M Miss $15.414M Estimate

BenzingaMay 7 16:48 ET

Express News | Ocular Therapeutix Inc: Cash Expected to Support Operations Into 2028, Based on $482.9M March 31, 2024, Cash Balance

ReutersMay 7 16:45 ET

Ocular Therapeutix | 10-Q: Quarterly report

Futu NewsMay 7 16:27 ET · Announcements

Earnings Flash (OCUL) OCULAR THERAPEUTIX Posts Q1 Revenue $14.8M, Vs. Street Est of $15.4M

04:19 PM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (OCUL) OCULAR THERAPEUTIX Posts Q1 Revenue $14.8M, vs. Street Est of $15.4M

MT NewswiresMay 7 16:19 ET

Express News | Ocular Therapeutix Q1 Product Revenue USD 14.715 Million

ReutersMay 7 16:05 ET